Market Research Logo

Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis

Both prescription and over-the-counter (OTC) drugs must be manufactured in accordance with standards established by the Food and Drug Administration (FDA). The agency inspects manufacturing facilities before a drug application can be approved. Any manufacturing deficiencies found would need to be corrected before approval.

Current Good Manufacturing Practices (cGMPs) refers to the regulations enforced by the FDA. The cGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities.

Adherence to the cGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. This includes establishing strong quality management systems, obtaining appropriate quality raw materials, establishing robust operating procedures, detecting and investigating product quality deviations, and maintaining reliable testing laboratories. This formal system of controls at a pharmaceutical company, if adequately put into practice, helps to prevent instances of contamination, mix-ups, deviations, failures, and errors. This assures that drug products meet their quality standards.

The cGMP requirements were established to be flexible in order to allow each manufacturer to decide individually how to best implement the necessary controls by using scientifically sound design, processing methods, and testing procedures. The flexibility in these regulations allows companies to use modern technologies and innovative approaches to achieve higher quality through continual improvement.

  • Use of RFID in serialized unique packaging numbering to authenticate and check for recall/expiry status.
  • Use of X-ray and metal detection systems to detect glass, stone, bone, rubber and other contaminants
  • Use of checkweighers and sorters
  • Use of baggers capable of handling, opening and sealing bags manufactured from specialist sterile films and papers.
  • Use of quality control labeling systems

It is important to note that cGMPs are minimum requirements. Many pharmaceutical manufacturers are already implementing comprehensive, modern quality systems and risk management approaches that exceed these minimum standards. This is important because a consumer cannot detect through smell, touch, or sight if a drug product is safe or if it will work.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Manufacturing, Packaging & Detailing Industry Research & Market Reports

  • Pediatric Drugs Markets in China

    ...economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Anti-Tumor Drugs Companies in China

    ...of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More

  • Lymphoma Treatment Drugs Companies in China

    ...dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More

  • Pneumonia Treatment Drugs Companies in China

    ...dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies ... Read More

  • Incretion Drugs Companies in China

    ...of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More

  • Autoimmune Drugs Markets in China

    ...economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic ... Read More

  • Antibiotics Markets in China

    ...a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment ... Read More

  • Pneumonia Treatment Drugs Markets in China

    ...The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines ... Read More

  • Global L-Carnitine Hydrochlorid Market Research Report 2017

    ...focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the L-Carnitine Hydrochlorid basics: definitions, classifications, applications ... Read More

  • Global Phosphatidylserine Market Research Report 2017

    ...the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Phosphatidylserine basics: definitions, classifications, applications and market overview; ... Read More

  • Global Glucose Chloride Injection Market Research Report 2017

    ...market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Glucose Chloride Injection basics: ... Read More

  • Lactic Acid Market Analysis By Application (Industrial, F&B, Pharmaceuticals, Personal Care) & Polylactic Acid (PLA) Market Analysis By Application (Packaging, Agriculture, Transport, Electronics, Textiles), And Segment Forecasts, 2014 - 2025

    ...& polylactic acid market is expected to reach USD 9.8 billion and USD 6.5 billion respectively by 2025, according to a new report by Grand View Research, Inc. Rising demand for lactic acid as pH ... Read More

  • Healthcare Providers Global Industry Almanac 2017

    ...the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis Essential resource for top-line data and analysis covering the global healthcare providers market. Includes market size and segmentation data, ... Read More

  • Brand Name Pharmaceutical Manufacturing in Canada - Industry Market Research Report

    ...drug utilization rates. As the cost discrepancy between generic and brand-name drugs has risen, many public and private payers have aimed to bolster generic drug use, intensifying competition for the industry. Still, industry revenue is ... Read More

  • Angola Pharmaceuticals and Healthcare Report Q3 2017

    ...fever. Recovering oil prices should see a notable improvement in the Angolaneconomy in 2017 and 2018, which will lead to an increase in government funding for healthcareinfrastructure projects and immunisation campaigns. However, a weak regulatory ... Read More

  • Bahrain Pharmaceuticals and Healthcare Report Q3 2017

    ...the Gulf region will derail any meaningful investment away fromBahrain's underdeveloped market. In common with other Gulf states, the Bahraini government mayincreasingly look to pharmaceutical manufacturing to reduce oil dependence, providing opportunities fordrugmakers to establish ... Read More

  • United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2017

    ...anticipate strong opportunities for domestic and international firms,despite the proliferation of cost-containment initiatives across the GCC. Headline Expenditure Projections Pharmaceuticals: AED9.61bn (USD2.62bn) in 2016 to AED10.43bn (USD2.84bn) in 2017; +8.5% inlocal currency terms and +8.6% ... Read More

  • Bulgaria Pharmaceuticals and Healthcare Report Q3 2017

    ...isa region-wide trend, brought about by healthcare payers seeking to garner the greatest value from theirbudgets given widespread austerity and public expenditure scrutiny since the global financial crisis.Consequently, we expect greater rationalisation of medicine prescription ... Read More

  • Czech Republic Pharmaceuticals and Healthcare Report Q3 2017

    ...for innovative medicines, coupled with a developed regulatoryenvironment, will maintain the Czech Republic's attractiveness to innovative drugmakers. Headline Expenditure Projections Pharmaceuticals: CZK80.25bn (USD3.27bn) in 2016 to CZK83.86bn (USD3.69bn) in 2017; 4.5% inlocal currency terms and ... Read More

  • United Kingdom Pharmaceuticals and Healthcare Report Q3 2017

    ...challenges that drugmakers face in the UK, not tomention the implications of the country's vote to leave the EU, the UK's pharmaceutical market is one of thelargest in Europe and, as such, remains a key ... Read More

  • Belarus Pharmaceuticals and Healthcare Report Q3 2017

    ...rewards to drugmakers; however investment within thecountry's healthcare system will boost medicine demand. The Belarusian market will remain one of theregion's medicine sales outperformers and therefore represents an attractive market for legacy productsand generic medicine ... Read More

  • Algeria Pharmaceuticals and Healthcare Report Q3 2017

    ...treatment, creatingcommercial opportunities for drugmakers and health sector providers. That said, Algeria will remain ahigh-risk market for innovative drugmakers given the weak regulatory environment and market accessrestrictions. We expect new legislation to gradually improve the ... Read More

  • Argentina Pharmaceuticals and Healthcare Report Q3 2017

    ...demand for chronic disease treatment. That said, Argentina will remain ahigh risk market to innovative drugmakers in the short term due to a subdued regulatory environment. However, ongoing improvements in the intellectual property protection system ... Read More

  • Binge Eating Disorder - Pipeline Review, H1 2017

    ...Disorder (Central Nervous System) pipeline landscape. Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting ... Read More

  • Raptor Pharmaceutical Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    ...on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Raptor Pharmaceutical Corp. since January2007. Synopsis Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports ... Read More

3 4 5 6 8 10 11 12